| Literature DB >> 29387371 |
Basiru O Ajiboye1,2, Hussein O B Oloyede1, Musa O Salawu1.
Abstract
This study was aimed at investigating the antihyperglycemic and antidyslipidemic activity of Musa paradisiaca-based diets in alloxan-induced diabetic mellitus rats. Diabetes was induced by a single intraperitoneal injection of alloxan (150 mg/kg b.w) in 48 randomly selected rats. The rats were randomly grouped into four as follows: normal rats fed Dioscorea rotundata-based diet, diabetic control rats fed D. rotundata-based diet, diabetic rats fed D. rotundata-based diet and administered metformin (14.2 mg/kg body weight) orally per day, and diabetic rats fed M. paradisiaca-based diet. Body weight and fasting blood glucose level were monitored, on 28th days the rats were sacrificed, liver was excised. Thereafter, the hyperglycemic and dyslipidemic statii of the induced diabetic animals were determined. The M. paradisiaca-based diet significantly (p < .05) reversed the levels of fasting blood glucose, with significant (p < .05) increase in insulin and glycogen concentrations. The diet also increased the activity of hexokinase with significant reduction (p < .05) in glucose-6-phosphatase and fructose-1-6-diphosphatase activities. M. paradisiaca-based diet demonstrated significant reduction (p < .05) in cholesterol, triacylglycerol (TG), very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), and significant increase (p < .05) in high-density lipoprotein (HDL) compared with those of diabetic control group. Also, M. paradisiaca-based diet significantly (p < .05) reversed the activities of aspartate aminotransferase and alanine aminotransferase when compared with diabetic control animals. The consumption of this diet may be useful in ameliorating hyperglycemia and dyslipidemia in diabetes mellitus patients.Entities:
Keywords: Musa paradisiaca; dyslipidemia; hyperglycemia; unripe
Year: 2017 PMID: 29387371 PMCID: PMC5778235 DOI: 10.1002/fsn3.538
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 2.863
Compounded diets (g) for different groups of animals
| Drugs/ingredients | Group I | Group II | Group III | Group IV |
|---|---|---|---|---|
| DF | 57.60 | — | — | — |
| A+DF | — | 57.60 | — | — |
| A+DF+M | — | — | 57.60 | — |
| A+UMP | — | — | — | 57.60 |
| Cellulose | 6.00 | 6.00 | 6.00 | 6.00 |
| Soybean | 25.00 | 25.00 | 25.00 | 25.00 |
| Soybeans oil | 6.00 | 6.00 | 6.00 | 6.00 |
|
| 5.00 | 5.00 | 5.00 | 5.00 |
| D‐methionine | 0.40 | 0.40 | 0.40 | 0.40 |
A, alloxan; DF, Dioscorea rotundata (white yam flour); M, metformin; UMP, unripe Musa paradisiaca (unripe plantain).
*Mineral mix contained (g/ kg diet): CaCO3 (15.258), CoCl2.6H2O (0.001), ZnCl2 (0.001), CuSO4.5H2O (0.019), FeSO4.7H2O (1.078), MgSO4 (2.929), MnSO4.2H2O (0.178), KI (0.032), KH2PO4 (15.559) and NaCl (5.573), while the vitamin mix contained (g/kg diets): thiamine (0.02), riboflavin (0.03), pyridoxine (0.01), P‐aminobenzoic acid (0.20), myo‐inositol (2.00), biotin (0.001), menadione (0.01), ergocalciferol (0.4), choline‐HCl (2.0), and cellulose (3.31), α–tocopherol acetate (50 IU), retinal palmitate (4000IU), calcium pantothenate (0.0016) and folic acid (0.0002).
Macro‐ and micronutrient compositions of the compounded diets
| Parameters (%) | Diet A ( | Diet B ( |
|---|---|---|
|
| ||
| Ash | 2.39 ± 0.15a | 8.20 ± 0.12b |
| Lipid content | 6.50 ± 0.12a | 8.22 ± 0.12b |
| Crude fiber | 8.39 ± 0.04a | 16.62 ± 0.04b |
| Protein | 16.89 ± 0.07a | 19.49 ± 0.0b |
| Moisture content | 1.68 ± 0.39a | 1.87 ± 0.23a |
| Carbohydrate (by difference) | 64.27 ± 0.35a | 45.50 ± 0.42b |
|
| ||
| Arabinose (mg/100 g) | 2.40 ± 0.01a | 3.43 ± 0.12b |
| Fructose (mg/100 g) | 2.60 ± 0.02a | 4.40 ± 0.11b |
| IDF (%) | 2.00a ± 0.02a | 4.28 ± 0.20b |
| SDF (%) | 6.39 ± 0.05a | 12.320.02b |
|
| ||
| Mg | 38.96 ± 0.32a | 64.20 ± 0.02b |
| Zn | 10.21 ± 0.02a | 17.81 ± 0.06b |
| Se | 0.21 ± 0.32a | 1.40 ± 0.02b |
| Na | 248.21 ± 0.02a | 649.01 ± 0.34b |
| Ca | 1.32 ± 0.02a | 3.92 ± 0.03b |
| K | 134.05 ± 0.02a | 158.11 ± 0.02b |
| Fe | 1.02 ± 0.42a | 3.89 ± 0.02b |
|
| ||
| A | 28.32 ± 0.02a | 154.72 ± 0.22b |
| D | 8.32 ± 0.09a | 20.38 ± 0.02b |
| E | 0.11 ± 0.08a | 4.92 ± 0.34b |
| K | 0.09 ± 0.02a | 0.12 ± 0.02b |
| C | 0.94 ± 0.32a | 5.49 ± 0.05b |
|
| ||
| Glycine | 1.89 ± 0.01a | 2.99 ± 0.09b |
| Alanine | 3.24 ± 1.02a | 7.99 ± 0.04b |
| Serine | 3.21 ± 0.12a | 5.99 ± 0.22b |
| Proline | 3.82 ± 1.00a | 8.21 ± 0.50b |
| Valine | 2.96 ± 1.02a | 5.00 ± 0.05b |
| Threonine | 1.48 ± 0.22a | 3.24 ± 0.05b |
| Isoleucine | 2.40 ± 0.12a | 4.42 ± 0.05b |
| Leucine | 4.90 ± 1.02a | 9.99 ± 0.05b |
| Aspartate | 5.20 ± 0.02a | 5.89 ± 0.04b |
| Lysine | 2.20 ± 0.02a | 3.24 ± 0.02b |
| Methionine | 1.20 ± 0.02a | 4.29 ± 0.02b |
| Glutamate | 12.20 ± 2.02a | 18.20 ± 0.01b |
| Phenylalanine | 3.26 ± 0.02a | 4.20 ± 0.02b |
| Histidine | 2.22 ± 0.02a | 4.52 ± 0.02b |
| Arginine | 3.27 ± 0.02a | 3.94 ± 0.02b |
| Tyrosine | 1.01 ± 0.02a | 2.92 ± 0.02b |
| Cysteine | 1.16 ± 0.02a | 1.52 ± 0.02b |
|
| ||
| Caprylic acid | 0.05 ± 0.01a | 0.09 ± 0.01b |
| Palmitic acid | 10.98 ± 0.01a | 18.98 ± 0.01b |
| Palmitoleic acid | 0.35 ± 0.01a | 1.12 ± 0.01b |
| Stearic acid | 3.62 ± 0.01a | 5.79 ± 0.01b |
| Oleic acids | 18.32 ± 0.01a | 25.89 ± 0.01b |
| Linoleic acid | 40.89 ± 0.01a | 44.60 ± 0.01b |
| Linolenic acid | 1.20 ± 0.01a | 2.96 ± 0.01b |
| Arachidic acid | 1.10 ± 0.01a | 1.14 ± 0.01b |
| Arachidonic acid | 0.06 ± 0.01a | 0.14 ± 0.01b |
|
| ||
| Total phenol (mg/g) | 2.84 ± 0.02a | 3.33 ± 0.01b |
| Total flavonoid (mg/g) | 1.99 ± 0.20a | 2.27 ± 0.30b |
| FRAP (%) | 1.60 ± 0.09a | 6.59 ± 0.03b |
| NO (%) | 2.34 ± 0.03a | 6.16 ± 0.08b |
| Fe2+ chelation (%) | 34.23 ± 0.03a | 57.76 ± 0.05b |
| DPPH (%) | 23 01 ± 0.02a | 41.231 ± 0.01b |
| OH (%) | 6.04 ± 0.02a | 9.52 ± 0.02b |
Each value is a mean of three determinations ± SEM. Values with different superscripts across the rows are significantly different (p < .05).
FRAP, ferric reducing antioxidant power; NO, nitric oxide; OH, hydroxy radical; DPPH, 2,2‐diphenyl‐1‐picrylhydrazyl; IDF, insoluble dietary fiber; SDF, soluble dietary fiber.
*Glucogenic amino acids.
†Nonessential amino acids.
‡Essential amino acids.
Compounded diets on food intake (g/day) of alloxan‐induced diabetic rats
| Groups | Week 1 | Week 2 | Week 3 | Week 4 |
|---|---|---|---|---|
| Normal control | 18.23 ± 1.22a | 20.15 ± 2.22a | 24.23 ± 2.10a | 28.89 ± 2.16a |
| Diabetic control | 25.24 ± 2.16b | 30.34 ± 2.86b | 36.69 ± 2.46d | 46.29 ± 1.16d |
| Metformin | 25.89.± 2.11b | 29.56 ± 2.63b | 34.50 ± 1.78c | 41.23 ± 2.00c |
|
| 26.18 ± 2 .20b | 29.68 ± 2.32b | 32.34 ± 1.65b | 38.45 ± 1.89b |
Each value is a mean of 11 determinations ± SEM. Values with different superscripts along the column are significantly different (p < .05).
Compounded diets on the body weight changes (g) of alloxan‐induced diabetic rats
| Groups | Initial body weight | Final body weight | Percentage weight gain/loss |
|---|---|---|---|
| Normal control | 150.21 ± 4.62a | 177.45 ± 2.45a | 18.13 ± 2.89a |
| Diabetic control | 148.12 ± 6.21a | 99.75 ± `1.77d | −32.66 ± 1.66d |
| Metformin | 150.23 ± 4.21a | 119.73 ± 2.11c | −20.30 ± 1.07c |
|
| 146.32 ± 5.60a | 135.82 ± 1.02b | −7.18 ± 1.65b |
Each value is a mean of 11 determinations ± SEM. Values with different superscripts along the column are significantly different (p < .05).
Figure 1Fasting blood glucose levels (mg/dl) of alloxan‐induced diabetic rats fed Musa paradisiaca‐based diet. Each value is a mean of 11 determinations ± SEM, Values with different superscripts are significantly different (p < .05)
Serum lipid profile of alloxan‐induced diabetic rats fed Musa paradisiaca‐based diet for 4 weeks
| Groups | Cholesterol (mmol/L) | TG (mmol/L) | HDL (mmol/L) | VLDL (mmol/L) | LDL (mmol/L) |
|---|---|---|---|---|---|
| Normal control | 75.48 ± 0.25a | 43.71 ± 0.09a | 34.18 ± 0.04a | 19.87 ± 0.19a | 21.19 ± 0.03a |
| Diabetic control | 117.55 ± 0.13d | 67.03 ± 0.01c | 17.05 ± 0.01c | 30.47 ± 0.02b | 69.94 ± 0.12d |
| Metformin | 77.91 ± 0.05b | 43.52 ± 0.12a | 34.70 ± 0.62a | 19.78 ± 0.21a | 22.76 ± 0.10b |
|
| 81.39 ± 0.09c | 44.51 ± 0.40b | 33.85 ± 0.04b | 19.93 ± 0.20a | 27.11 ± 0.02c |
Each value is a mean of 11 determinations ± SEM. Values with different superscripts along the column are significantly different (p < .05).
HDL, high‐density lipoprotein; VLDL, very low‐density lipoprotein; LDL, low‐density lipoprotein.
Figure 2Hepatic glycogen (mmol/l) and serum insulin concentrations (μIu/ml) of alloxan‐induced diabetic rats fed Musa paradisiaca‐based diet for 4 weeks. Each value is a mean of 11 determinations ± SEM, Values with different superscripts are significantly different (p < .05)
Some hepatic carbohydrate metabolism enzymes activities in tissues of alloxan‐induced diabetic rats fed Musa paradisiaca‐based diet for 4 weeks
| Groups | Gluocose‐6‐phosphatase (μm of glucose phosporylated/hr/mg/dl) | Hexokinase (μm of Pi liberated/hr/mg/dl) | Fructose 1,6 diphosphatase (μm of Pi liberated/hr/mg/dl) |
|---|---|---|---|
| Normal control | 845.36 ± 2.32a | 156.10 ± 0.17a | 400.18 ± 0.35a |
| Diabetic control | 1357.2 ± 6.12d | 100.48 ± 0.37d | 770.41 ± 8.14d |
| Metformin | 904.24 ± 2.94b | 154.71 ± 0.08b | 431.17 ± 0.41b |
|
| 971.98 ± 1.61c | 140.29 ± 0.11c | 445.11 ± 0.06c |
Each value is a mean of 11 determinations ± SEM. Values with different superscripts along the column are significantly different (p < .05).
Figure 3Activities of AST and ALT in liver of alloxan‐induced diabetic rats fed Musa paradisiaca‐based diet for 4 weeks. Each value is a mean of 11 determinations ± SEM, Values with different superscripts are significantly different (p < .05). NC: normal control, DC: diabetic control, METF: metformin, MPBD: Musa paradisiaca‐based diet, AST: aspartate aminotransferase and ALT: alanine aminotransferase